In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.

It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP ...

Fintel reports that on December 6, 2024, Jefferies initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...

Mereo Biopharma Group Plc (MREO) has received a new Buy rating, initiated by Jefferies analyst, Maury Raycroft.Don't Miss our Black Friday ...